MiMedx Group, Inc.
MDXG
$4.27
$0.071.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.36% | 10.51% | 19.99% | 14.77% | 6.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.36% | 10.51% | 19.99% | 14.77% | 6.85% |
| Cost of Revenue | 11.34% | 15.99% | 21.54% | 24.31% | 19.47% |
| Gross Profit | -5.49% | 9.30% | 19.67% | 12.87% | 4.34% |
| SG&A Expenses | 6.56% | 17.44% | 23.02% | 20.95% | 14.78% |
| Depreciation & Amortization | 42.64% | -4.75% | -42.41% | -33.94% | -23.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.07% | 17.37% | 22.51% | 21.61% | 15.66% |
| Operating Income | -79.75% | -27.11% | 7.72% | -15.23% | -31.72% |
| Income Before Tax | -73.96% | -22.34% | 15.66% | -7.07% | -23.60% |
| Income Tax Expenses | -57.06% | -20.04% | 15.61% | 157.51% | 142.75% |
| Earnings from Continuing Operations | -80.48% | -23.18% | 15.67% | -52.44% | -63.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.00% | -89.59% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.61% | -23.60% | 14.52% | -53.85% | -63.81% |
| EBIT | -79.75% | -27.11% | 7.72% | -15.23% | -31.72% |
| EBITDA | -62.02% | -15.77% | 20.53% | 1.64% | -19.61% |
| EPS Basic | -80.73% | -23.96% | 13.83% | -56.24% | -65.59% |
| Normalized Basic EPS | -74.25% | -23.18% | 11.38% | -14.42% | -31.56% |
| EPS Diluted | -82.66% | -26.85% | 12.42% | -54.89% | -65.06% |
| Normalized Diluted EPS | -75.23% | -23.58% | 11.54% | -9.96% | -24.81% |
| Average Basic Shares Outstanding | 0.57% | 0.64% | 0.59% | 5.36% | 11.26% |
| Average Diluted Shares Outstanding | -0.08% | 0.25% | 0.39% | 0.43% | -0.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |